In this case, we determined a significant difference for S100A4 and MRC2, detecting an increased expression of both molecules for the tumor group, but conclusive results could only be obtained for MRC2 (details in Supplementary Figures S7–S9). The gene discussed is S100A4; the disease is neoplasm.